Exor N.V. has recently submitted an amended 13F report, revealing its investment holdings as of March 31, 2025. This filing, made on November 13, 2026, is significant as it reflects Exor's strategic adjustments in its portfolio, which could influence investment trends across the industry.

Exor N.V. is an investment company based in Amsterdam, Netherlands. It operates under the Central Index Key (CIK) number 0001589122. The company has a history of investing in various sectors, including automotive and luxury goods. Its recent filings include multiple amendments and reports, showcasing its active management strategy.

The amended filing indicates that Exor N.V. has made significant investments in several companies. Notably, it holds a substantial stake in Ferrari N.V., valued at approximately $16.16 billion. Other key investments include CNH Industrial N.V., Ermenegildo Zegna N.V., Neumora Therapeutics Inc., and Stellantis N.V. The total value of the reported holdings amounts to over $25.73 billion.

"The filing reflects a strategic adjustment in Exor's portfolio, highlighting its commitment to key sectors," said Guido de Boer, Chief Financial Officer of Exor N.V.

This update may affect various stakeholders, including investors, analysts, and competitors within the automotive and luxury goods sectors. Companies like Ferrari and Stellantis, which are part of Exor's portfolio, may experience increased scrutiny regarding their performance and market strategies following this disclosure.

As for what’s next, the filing does not specify any forthcoming actions or additional filings. However, industry observers will likely keep a close eye on Exor's future moves and any further amendments to its investment strategy.